Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.

Miura K, Deng B, Wu Y, Zhou L, Pham TP, Diouf A, Wu CK, Lee SM, Plieskatt JL, Morin MJ, Long CA.

Vaccine. 2019 Apr 3;37(15):2073-2078. doi: 10.1016/j.vaccine.2019.02.071. Epub 2019 Mar 5.

2.

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Kundu P, Semesi A, Jore MM, Morin MJ, Price VL, Liang A, Li J, Miura K, Sauerwein RW, King CR, Julien JP.

Nat Commun. 2018 Oct 26;9(1):4458. doi: 10.1038/s41467-018-06742-9.

3.

Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.

Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, Lee CK, Ockenhouse CF, Morin MJ, Streatfield SJ, Yusibov V.

Vaccine. 2018 Sep 18;36(39):5865-5871. doi: 10.1016/j.vaccine.2018.08.033. Epub 2018 Aug 17.

4.

Transcriptome analysis based detection of Plasmodium falciparum development in Anopheles stephensi mosquitoes.

Oakley MS, Verma N, Myers TG, Zheng H, Locke E, Morin MJ, Tripathi AK, Mlambo G, Kumar S.

Sci Rep. 2018 Aug 1;8(1):11568. doi: 10.1038/s41598-018-29969-4.

5.

Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.

Othman AS, Lin JW, Franke-Fayard BM, Kroeze H, van Pul FJA, Chevalley-Maurel S, Ramesar J, Marin-Mogollon C, Jore MM, Morin MJ, Long CA, Sauerwein R, Birkett A, Miura K, Janse CJ, Khan SM.

Mol Biochem Parasitol. 2018 Sep;224:44-49. doi: 10.1016/j.molbiopara.2018.07.009. Epub 2018 Jul 24.

6.

Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density.

Sherrard-Smith E, Sala KA, Betancourt M, Upton LM, Angrisano F, Morin MJ, Ghani AC, Churcher TS, Blagborough AM.

Elife. 2018 Jun 19;7. pii: e35213. doi: 10.7554/eLife.35213.

7.

Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.

Eldering M, Bompard A, Miura K, Stone W, Morlais I, Cohuet A, van Gemert GJ, Brock PM, Rijpma SR, van de Vegte-Bolmer M, Graumans W, Siebelink-Stoter R, Da DF, Long CA, Morin MJ, Sauerwein RW, Churcher TS, Bousema T.

Parasit Vectors. 2017 Oct 17;10(1):489. doi: 10.1186/s13071-017-2414-z.

8.

A Direct from Blood Reverse Transcriptase Polymerase Chain Reaction Assay for Monitoring Falciparum Malaria Parasite Transmission in Elimination Settings.

Taylor BJ, Lanke K, Banman SL, Morlais I, Morin MJ, Bousema T, Rijpma SR, Yanow SK.

Am J Trop Med Hyg. 2017 Aug;97(2):533-543. doi: 10.4269/ajtmh.17-0039. Epub 2017 Jul 19.

9.

A no film slot blot for the detection of developing P. falciparum oocysts in mosquitoes.

Grabias B, Verma N, Zheng H, Tripathi AK, Mlambo G, Morin MJ, Locke E, Kumar S.

PLoS One. 2017 Apr 21;12(4):e0174229. doi: 10.1371/journal.pone.0174229. eCollection 2017.

10.

A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials.

Gazda LS, Collins J, Lovatt A, Holdcraft RW, Morin MJ, Galbraith D, Graham M, Laramore MA, Maclean C, Black J, Milne EW, Marthaler DG, Vinerean HV, Michalak MM, Hoffer D, Richter S, Hall RD, Smith BH.

Xenotransplantation. 2016 Nov;23(6):444-463. doi: 10.1111/xen.12277. Epub 2016 Nov 11.

PMID:
27862363
11.

Health Services and Health Care Needs Fulfilled by Structured Clinical Programs for Children with Medical Complexity.

Kuo DZ, Berry JG, Glader L, Morin MJ, Johaningsmeir S, Gordon J.

J Pediatr. 2016 Feb;169:291-6.e1. doi: 10.1016/j.jpeds.2015.10.010. Epub 2015 Oct 31.

12.

A slot blot immunoassay for quantitative detection of Plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst.

Kumar S, Zheng H, Deng B, Mahajan B, Grabias B, Kozakai Y, Morin MJ, Locke E, Birkett A, Miura K, Long C.

PLoS One. 2014 Dec 22;9(12):e115807. doi: 10.1371/journal.pone.0115807. eCollection 2014.

13.

Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.

Nunes JK, Woods C, Carter T, Raphael T, Morin MJ, Diallo D, Leboulleux D, Jain S, Loucq C, Kaslow DC, Birkett AJ.

Vaccine. 2014 Sep 29;32(43):5531-9. doi: 10.1016/j.vaccine.2014.07.030. Epub 2014 Jul 29.

14.

A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein.

Kumar S, Zheng H, Sangweme DT, Mahajan B, Kozakai Y, Pham PT, Morin MJ, Locke E, Kumar N.

J Immunol Methods. 2013 Apr 30;390(1-2):99-105. doi: 10.1016/j.jim.2013.02.001. Epub 2013 Feb 8.

PMID:
23399449
15.

An inactivated cell-culture vaccine against yellow fever.

Monath TP, Fowler E, Johnson CT, Balser J, Morin MJ, Sisti M, Trent DW.

N Engl J Med. 2011 Apr 7;364(14):1326-33. doi: 10.1056/NEJMoa1009303.

16.

Diagnosing acute appendicitis in adults.

Morin MJ.

AJR Am J Roentgenol. 2008 Dec;191(6):W315; author reply W316. doi: 10.2214/AJR.08.1409. No abstract available.

PMID:
19020223
17.

Design and implementation of an HIV/AIDS electronic medical record system (HIV/AIDS EMR) in the Philippines.

Zabat GM, Caoili JC, Anduyon A, Ramos GJ, Morin MJ, Ditangco RA, Tactacan-Abrenica RJ, Ilustre JR, Tupasi TE.

AMIA Annu Symp Proc. 2007 Oct 11:1166.

PMID:
18694262
18.
19.

Intracardiac yolk sac tumor and dysrhythmia as an etiology of pediatric syncope.

Morin MJ, Hopkins RA, Ferguson WS, Ziegler JW.

Pediatrics. 2004 Apr;113(4):e374-6.

PMID:
15060271
20.

Developmental variability in expression and regulation of inducible nitric oxide synthase in rat intestine.

Morin MJ, Karr SM, Faris RA, Gruppuso PA.

Am J Physiol Gastrointest Liver Physiol. 2001 Aug;281(2):G552-9.

22.

Helical CT and renal calculi.

Morin MJ.

AJR Am J Roentgenol. 2000 Feb;174(2):568-9. No abstract available.

PMID:
10658744
23.

Pharmacological rescue of mutant p53 conformation and function.

Foster BA, Coffey HA, Morin MJ, Rastinejad F.

Science. 1999 Dec 24;286(5449):2507-10.

24.

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ.

J Pharmacol Exp Ther. 1999 Nov;291(2):739-48.

PMID:
10525095
25.
27.

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, DiOrio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P.

Cancer Res. 1997 Nov 1;57(21):4838-48.

28.

Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats.

Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP.

Gastroenterology. 1997 Oct;113(4):1246-57.

PMID:
9322519
29.

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs.

Robinson HL, Boyle CA, Feltquate DM, Morin MJ, Santoro JC, Webster RG.

J Infect Dis. 1997 Aug;176 Suppl 1:S50-5.

PMID:
9240695
30.

Serotype-dependent induction of pulmonary neutrophilia and inflammatory cytokine gene expression by reovirus.

Farone AL, Frevert CW, Farone MB, Morin MJ, Fields BN, Paulauskis JD, Kobzik L.

J Virol. 1996 Oct;70(10):7079-84.

31.

DNA vaccines.

Robinson HL, Lu S, Feltquate DM, Torres CT, Richmond J, Boyle CM, Morin MJ, Santoro JC, Webster RG, Montefiori D, Yasutomi Y, Letvin NL, Manson K, Wyand M, Haynes JR.

AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):455-7. Review. No abstract available.

PMID:
8962755
32.
33.
34.

A pathway for entry of reoviruses into the host through M cells of the respiratory tract.

Morin MJ, Warner A, Fields BN.

J Exp Med. 1994 Oct 1;180(4):1523-7.

35.

Potentiation of butyrate-induced differentiation in human colon tumor cells by deoxycholate.

Desai TK, Nathan DF, Morin MJ.

Cancer Lett. 1993 May 14;69(3):181-6.

PMID:
8513444
36.
37.
39.

Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance.

Posada JA, McKeegan EM, Worthington KF, Morin MJ, Jaken S, Tritton TR.

Cancer Commun. 1989;1(5):285-92.

PMID:
2577153
41.

Disparate effects of activators of protein kinase C on HL-60 promyelocytic leukemia cell differentiation.

Morin MJ, Kreutter D, Rasmussen H, Sartorelli AC.

J Biol Chem. 1987 Aug 25;262(24):11758-63.

42.

Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site.

Collins CJ, Underdahl JP, Levene RB, Ravera CP, Morin MJ, Dombalagian MJ, Ricca G, Livingston DM, Lynch DC.

Proc Natl Acad Sci U S A. 1987 Jul;84(13):4393-7.

43.

Function of the anthracycline amino group in cellular transport and cytotoxicity.

Burke TG, Morin MJ, Sartorelli AC, Lane PE, Tritton TR.

Mol Pharmacol. 1987 May;31(5):552-6.

PMID:
3472065
44.

Mechanisms involved in the induction of malignant cell differentiation.

Sartorelli AC, Ishiguro K, King CL, Morin MJ, Reiss M.

Adv Enzyme Regul. 1986;25:507-29. Review.

PMID:
3544708
45.

Dissociation of protein kinase C activation from phorbol ester-induced maturation of HL-60 leukemia cells.

Kreutter D, Caldwell AB, Morin MJ.

J Biol Chem. 1985 May 25;260(10):5979-84.

46.

Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method.

Lynch DC, Zimmerman TS, Collins CJ, Brown M, Morin MJ, Ling EH, Livingston DM.

Cell. 1985 May;41(1):49-56.

PMID:
3873280
48.
49.

Effects of a membrane sugar analogue, 6-deoxy-6-fluoro-D-galactose, on the L1210 leukemic cell ectosialyltransferase system.

Morin MJ, Porter CW, Petrie CR 3rd, Korytnyk W, Bernacki RJ.

Biochem Pharmacol. 1983 Feb 1;32(3):553-61.

PMID:
6847704
50.

The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.

Morin MJ, Porter CW, McKernan P, Bernacki RJ.

J Cell Physiol. 1983 Feb;114(2):162-72.

PMID:
6822608

Supplemental Content

Loading ...
Support Center